Medicare Enrolled
Dr. Shelley Singh, D.O.
Rheumatology · Delray Beach, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Singh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Singh?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Singh
Dr. Shelley Singh is a rheumatology specialist in Delray Beach, FL, with 12 years of NPI registration. Based on federal Medicare data, Dr. Singh performed 119,856 Medicare services across 4,287 unique beneficiaries.
Between the years covered by Open Payments, Dr. Singh received a total of $10,346 from 40 pharmaceutical and/or device companies across 620 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Singh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 20% volume in FL
$10,346 industry payments
Medicare Practice Summary
Medicare Utilization ↗119,856
Medicare services
Top 20% in FL for rheumatology
4,287
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9,988 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
58,800 | $4 | $21 |
| Denosumab injection (Prolia/Xgeva) | 18,060 | $18 | $53 |
| Romosozumab injection (Evenity) for osteoporosis | 17,850 | $8 | $24 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
6,650 | $34 | $134 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
6,350 | $11 | $59 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
4,990 | $1 | $4 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,616 | $99 | $338 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
952 | $59 | $232 |
| Methotrexate sodium, 5 mg | 586 | $0 | $1 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
439 | $8 | $21 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
390 | $48 | $380 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
353 | $92 | $364 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
311 | $43 | $220 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
286 | $51 | $200 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
236 | $30 | $96 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
230 | $5 | $18 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
184 | $107 | $479 |
| Chronic care management services Comprehensive assessment and care planning for patients requiring ongoing chronic care management. |
145 | $51 | $166 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
119 | $128 | $533 |
| Viscosupplementation injection for joint An injection of hyaluronic acid or a derivative into a joint to provide lubrication and cushioning. |
103 | $59 | $380 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
95 | $31 | $105 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
89 | $11 | $73 |
| Limited ultrasound of joint or extremity A focused ultrasound exam of a specific joint or other structure in the arm or leg, excluding blood vessels. |
87 | $35 | $147 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
78 | $28 | $91 |
| Suprascapular nerve injection An injection of anesthetic and/or steroid medication into the suprascapular nerve in the shoulder area. |
69 | $37 | $439 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
69 | $71 | $238 |
| Ultrasound-guided small joint aspiration or injection This procedure involves removing fluid from or injecting medication into a small joint while using ultrasound imaging to guide the needle placement. |
65 | $74 | $283 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
65 | $29 | $91 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
58 | $27 | $90 |
| Pelvis X-ray, 1-2 views An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints. |
54 | $22 | $73 |
| Ultrasound-guided joint aspiration or injection Removal of fluid from or injection into a medium-sized joint using ultrasound guidance to ensure accurate placement. |
50 | $90 | $344 |
| Complete ultrasound scan of joint An ultrasound exam that uses sound waves to create detailed images of a joint. This procedure allows for the visualization of the joint's internal structures. |
46 | $45 | $242 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
45 | $34 | $107 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
44 | $13 | $62 |
| Hip X-ray, 2-3 views An X-ray imaging test of the hip joint using two to three different angles to visualize the bones and surrounding structures. |
41 | $39 | $123 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
39 | $29 | $172 |
| Additional 30 minutes of principal care management This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month. |
35 | $39 | $140 |
| Lower back and sciatic nerve injection An injection of an anesthetic and/or steroid medication into the lower back and sciatic nerve. This procedure delivers medication directly to the nerve site. |
27 | $132 | $443 |
| X-ray of both knees, standing An X-ray image of both knees taken while the patient is standing to assess bone alignment and joint space under weight-bearing conditions. |
26 | $33 | $106 |
| X-ray of upper spine, 4-5 views An X-ray imaging test of the upper spine using 4 to 5 different views to visualize the bones and structures in that area. |
25 | $42 | $139 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
24 | $23 | $104 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
20 | $4 | $17 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
19 | $1 | $3 |
| X-ray of both hips, 3-4 views An X-ray imaging test that captures 3 to 4 views of both hip joints to visualize the bones and surrounding structures. |
13 | $41 | $140 |
| X-ray of middle spine, 2 views An X-ray imaging test that produces two views of the middle section of the spine to visualize the bones and joints. |
12 | $25 | $86 |
| Elbow X-ray, 2 views An X-ray imaging test of the elbow joint using two different angles to visualize the bones and surrounding structures. |
11 | $24 | $77 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.0% high complexity
85.6% medium
3.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,346
Total received (2018-2024)
Avg $1,478/year across 7 years
Top 41% in FL for rheumatology
40
Companies
620
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,346 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,257
2023
$1,503
2022
$1,768
2021
$1,739
2020
$1,087
2019
$1,892
2018
$1,099
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$1,798
UCB, Inc.
$1,531
E.R. Squibb & Sons, L.L.C.
$893
Janssen Biotech, Inc.
$692
Radius Health, Inc.
$689
PFIZER INC.
$615
Novartis Pharmaceuticals Corporation
$600
AbbVie Inc.
$496
AstraZeneca Pharmaceuticals LP
$464
Janssen Scientific Affairs, LLC
$449
AbbVie, Inc.
$290
GlaxoSmithKline, LLC.
$221
ABBVIE INC.
$149
Sobi, Inc
$139
SANOFI-AVENTIS U.S. LLC
$117
Lilly USA, LLC
$116
SCILEX PHARMACEUTICALS INC.
$113
GENZYME CORPORATION
$103
Mallinckrodt Hospital Products Inc.
$94
Horizon Therapeutics plc
$90
DePuy Synthes Sales Inc.
$86
Takeda Pharmaceuticals U.S.A., Inc.
$76
Pacira Pharmaceuticals Incorporated
$75
SOBI, INC
$73
Genentech USA, Inc.
$40
Bioventus LLC
$40
Alkermes, Inc.
$40
Mallinckrodt Enterprises LLC
$30
Merck Sharp & Dohme Corporation
$28
Alexion Pharmaceuticals, Inc.
$27
ANI Pharmaceuticals, Inc.
$26
Horizon Pharma plc
$25
Zimmer Biomet Holdings, Inc.
$20
Organon Llc
$19
Mallinckrodt LLC
$16
Flexion Therapeutics, Inc.
$15
Hikma Pharmaceuticals USA
$14
West-Ward Pharmaceuticals
$13
Organon LLC
$13
Endo Pharmaceuticals Inc.
$12
Top 3 companies account for 40.8% of total payments
Associated products mentioned in payments ›
ACTHAR · ARISTADA · AVSOLA · Actemra · BENLYSTA · Bimzelx · COSENTYX · Cimzia · EVENITY · Enbrel · Entyvio · Exparel · FORTEO · GPS III PLATELET CONCENTRATION SYSTEM · HADLIMA · HUMIRA · Humira · ILARIS · INFLECTRA · Iovera · KEVZARA · KINERET · KRYSTEXXA · Kineret · LYBALVI · LYRICA · MONOVISC · Mitigare · ORENCIA · PURIFIED CORTROPHIN GEL · Prolia · REMICADE · RENFLEXIS · RINVOQ · Rinvoq · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · SUPARTZ FX SODIUM HYALURONATE · Strensiq · Supartz FX Sodium Hyaluronate · TALTZ · TREMFYA · Tymlos · Uloric · XELJANZ · XIAFLEX · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $9 per 100 Medicare services performed
Geographic Context
Rheumatologists within 10 mi
58
Per 100K population
3.8
County median income
$81,115
Nearest hospital
DELRAY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Singh is a mixed practice specialist, with above-average Medicare volume (top 20% in FL), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Singh experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Singh performed 58,800 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Singh receive payments from pharmaceutical companies?
Yes. Dr. Singh received a total of $10,346 from 40 companies across 620 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Singh's costs compare to other rheumatologists in Delray Beach?
Dr. Singh's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Singh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Delray Beach
Browse rheumatologists in Delray Beach ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in FL
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in FL
Which FL rheumatologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology